A lot of positivity swirling around this Aldosterone and Hypertension focused biotech.
1. Multiple recent positive top line results
2. recent Influx of capital for development, manufacturing and pre-commercialization activities
3. recent insider buying
4. increasing price and volume
I got lucky when buying in at $13, and was able to largely de-risk at 17. Currently a bit oversold, so on current trajectory watch and wait for a pullback to a better entry below $14.
Please also note the current market conditions indicate cautious buying, and while this may end up being a great biotech, a much larger percentage of these types of stocks will fail.
May the Fed be with you!
Not financial advice.
1. Multiple recent positive top line results
2. recent Influx of capital for development, manufacturing and pre-commercialization activities
3. recent insider buying
4. increasing price and volume
I got lucky when buying in at $13, and was able to largely de-risk at 17. Currently a bit oversold, so on current trajectory watch and wait for a pullback to a better entry below $14.
Please also note the current market conditions indicate cautious buying, and while this may end up being a great biotech, a much larger percentage of these types of stocks will fail.
May the Fed be with you!
Not financial advice.
Trade active
NOTE: it is currently a bit overbought (not oversold) which is what I meant to say. Anyway, the stock has potential. 
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.